{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:44:49Z","timestamp":1792107889492,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["grant number: 78369"],"award-info":[{"award-number":["grant number: 78369"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"DOI":"10.1007\/s10787-026-02429-6","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:53:08Z","timestamp":1792104788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leukotriene inhibitors in multiple sclerosis: a systematic review of animal studies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2540-6827","authenticated-orcid":false,"given":"Sina","family":"Pakkhesal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0594-0364","authenticated-orcid":false,"given":"Shideh","family":"Roshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6370-6090","authenticated-orcid":false,"given":"Ali","family":"Mehdizadeh Kahnamoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2609-1639","authenticated-orcid":false,"given":"Mahsa","family":"Aminzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2272-9299","authenticated-orcid":false,"given":"Sina","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-2946","authenticated-orcid":false,"given":"Farinaz","family":"Amirikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-3913","authenticated-orcid":false,"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2325-5631","authenticated-orcid":false,"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0109","authenticated-orcid":false,"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2429_CR1","doi-asserted-by":"publisher","first-page":"110959","DOI":"10.1016\/j.intimp.2023.110959","volume":"124","author":"BM Ahmed","year":"2023","unstructured":"Ahmed BM, Mansour NO, Sallam RA, Soliman MM (2023) Efficacy of montelukast as an adjuvant therapy in rheumatoid arthritis patients: a randomized controlled study. Int Immunopharmacol 124:110959. https:\/\/doi.org\/10.1016\/j.intimp.2023.110959","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2429_CR2","doi-asserted-by":"publisher","first-page":"22109","DOI":"10.1038\/s41598-026-53253-5","volume":"16","author":"A Alipour","year":"2026","unstructured":"Alipour A, Mosaddeghi-Heris R, Darvishi A, Parvaneh S, Talebi M, Taheri N, Talebi M, Naseri A (2026) The correlation between serum markers of oxidative stress and fatigue and related factors in minimally disabled patients with relapsing-remitting multiple sclerosis. Sci Rep 16(1):22109. https:\/\/doi.org\/10.1038\/s41598-026-53253-5","journal-title":"Sci Rep"},{"issue":"1","key":"2429_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.34172\/apb.2023.012","volume":"13","author":"AA Alizadeh","year":"2023","unstructured":"Alizadeh AA, Jafari B, Dastmalchi S (2023) Drug repurposing for identification of S1P1 agonists with potential application in multiple sclerosis using in silico drug design approaches. Adv Pharm Bull 13(1):113\u2013122. https:\/\/doi.org\/10.34172\/apb.2023.012","journal-title":"Adv Pharm Bull"},{"key":"2429_CR4","doi-asserted-by":"publisher","first-page":"157010","DOI":"10.1016\/j.cyto.2025.157010","volume":"194","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Alexiou A, Papadakis M, Batiha GE (2025) Dysregulation of the leukotriene pathway in Parkinson\u2019s disease: the potential role of montelukast. Cytokine 194:157010. https:\/\/doi.org\/10.1016\/j.cyto.2025.157010","journal-title":"Cytokine"},{"issue":"4","key":"2429_CR5","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1007\/s12035-024-04602-w","volume":"62","author":"N Bao","year":"2025","unstructured":"Bao N, Liu J, Wang H, Xing L, Xie Z, Liu C, Jin S, Jia J, Zhang M, Fan J (2025) Drug repurposing and screening for multiple sclerosis targeting microglia and macrophages. Mol Neurobiol 62(4):4724\u20134742. https:\/\/doi.org\/10.1007\/s12035-024-04602-w","journal-title":"Mol Neurobiol"},{"key":"2429_CR6","doi-asserted-by":"publisher","first-page":"110990","DOI":"10.1016\/j.jocn.2024.110990","volume":"132","author":"S Daneshvar","year":"2025","unstructured":"Daneshvar S, Moradi F, Rahmani M, Golshaniniya P, Frounchi N, Seifimansour S, Talebi M, Sanaie S, Naseri A (2025) Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis: a systematic review. J Clin Neurosci 132:110990. https:\/\/doi.org\/10.1016\/j.jocn.2024.110990","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2429_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/BF01993269","volume":"34","author":"D Fretland","year":"1991","unstructured":"Fretland D, Widomski D, Shone R, Levin S, Gaginella T (1991) Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig. Agents Actions 34(1):172\u2013174","journal-title":"Agents Actions"},{"issue":"1","key":"2429_CR8","first-page":"3454212","volume":"2017","author":"P Gelosa","year":"2017","unstructured":"Gelosa P, Colazzo F, Tremoli E, Sironi L, Castiglioni L (2017) Cysteinyl leukotrienes as potential pharmacological targets for cerebral diseases. Mediat Inflamm 2017(1):3454212","journal-title":"Mediat Inflamm"},{"issue":"4","key":"2429_CR9","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1084\/jem.183.4.1893","volume":"183","author":"RP Gladue","year":"1996","unstructured":"Gladue RP, Carroll LA, Milici AJ, Scampoli DN, Stukenbrok HA, Pettipher ER, Salter ED, Contillo L, Showell HJ (1996) Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J Exp Med 183(4):1893\u20131898. https:\/\/doi.org\/10.1084\/jem.183.4.1893","journal-title":"J Exp Med"},{"issue":"3","key":"2429_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4103\/1673-5374.380901","volume":"19","author":"P G\u00f6ttle","year":"2024","unstructured":"G\u00f6ttle P, Dietrich M, K\u00fcry P (2024) Multiple sclerosis drug repurposing for neuroregeneration. Neural Regen Res 19(3):507\u2013508. https:\/\/doi.org\/10.4103\/1673-5374.380901","journal-title":"Neural Regen Res"},{"issue":"2","key":"2429_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/imm.13308","volume":"163","author":"B Han","year":"2021","unstructured":"Han B, Zhang YY, Ye ZQ, Xiao Y, Rasouli J, Wu WC, Ye SM, Guo XY, Zhu L, Rostami A, Wang LB, Zhang Y, Li X (2021) Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model. Immunology 163(2):185\u2013200. https:\/\/doi.org\/10.1111\/imm.13308","journal-title":"Immunology"},{"issue":"5","key":"2429_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-0404.1992.tb04062.x","volume":"85","author":"M Haupts","year":"1992","unstructured":"Haupts M, Smektala K, Finkbeiner T, Simmet T, Gehlen W (1992) Immunoreactive leukotriene C4 levels in CSF of MS patients. Acta Neurol Scand 85(5):365\u2013367. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb04062.x","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2429_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1871527319666200825164123","volume":"21","author":"M Hoxha","year":"2022","unstructured":"Hoxha M, Spahiu E, Prendi E, Zappacosta B (2022) A systematic review on the role of arachidonic acid pathway in multiple sclerosis. CNS Neurol Disord Drug Targets 21(2):160\u2013187. https:\/\/doi.org\/10.2174\/1871527319666200825164123","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"2429_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12017-025-08895-5","volume":"28","author":"YJ Jung","year":"2026","unstructured":"Jung YJ, Choi H, Lee SM, Oh E (2026) Montelukast modulates MPTP-induced ferroptosis and neuroinflammation linked to the GPX4\/ACSL4\/5-LOX pathway. Neuromolecular Med 28(1):11. https:\/\/doi.org\/10.1007\/s12017-025-08895-5","journal-title":"Neuromolecular Med"},{"issue":"3","key":"2429_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2010.03.049","volume":"394","author":"Y Kihara","year":"2010","unstructured":"Kihara Y, Yokomizo T, Kunita A, Morishita Y, Fukayama M, Ishii S, Shimizu T (2010) The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 394(3):673\u2013678","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2429_CR16","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1080\/21655979.2021.1984003","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z, Wang J, Ma Y (2021) Montelukast attenuates interleukin IL-1\u03b2-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2). Bioengineered 12(1):8476\u20138484. https:\/\/doi.org\/10.1080\/21655979.2021.1984003","journal-title":"Bioengineered"},{"key":"2429_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/0102506882340597241218062725","author":"NMP Maideen","year":"2024","unstructured":"Maideen NMP, Rashid A, Nabi S A (2024) Montelukast-associated serious mental health adverse effects: an overview. New Emirates Med J. https:\/\/doi.org\/10.2174\/0102506882340597241218062725","journal-title":"New Emirates Med J"},{"issue":"6","key":"2429_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/13524585241240398","volume":"30","author":"AM Manuel","year":"2024","unstructured":"Manuel AM, Gottlieb A, Freeman L, Zhao Z (2024) Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: emulating clinical trials with retrospective administrative health claims data. Mult Scler 30(6):696\u2013706. https:\/\/doi.org\/10.1177\/13524585241240398","journal-title":"Mult Scler"},{"issue":"2","key":"2429_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/08923970903283662","volume":"32","author":"A Mirshafiey","year":"2010","unstructured":"Mirshafiey A, Jadidi-Niaragh F (2010) Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis. Immunopharmacol Immunotoxicol 32(2):219\u2013227","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"2429_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/imj.70023","volume":"55","author":"T Montague","year":"2025","unstructured":"Montague T, Drummond J, Ng K, Parratt J (2025) Advancements in multiple sclerosis. Intern Med J 55(6):895\u2013904. https:\/\/doi.org\/10.1111\/imj.70023","journal-title":"Intern Med J"},{"key":"2429_CR21","doi-asserted-by":"publisher","first-page":"106219","DOI":"10.1016\/j.msard.2024.106219","volume":"93","author":"A Moradi","year":"2025","unstructured":"Moradi A, Ebrahimian A, Sadigh-Eteghad S, Talebi M, Naseri A (2025) Sleep quality in multiple sclerosis: a systematic review and meta-analysis based on Pittsburgh sleep quality index. Mult Scler Relat Disord 93:106219. https:\/\/doi.org\/10.1016\/j.msard.2024.106219","journal-title":"Mult Scler Relat Disord"},{"key":"2429_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-026-05075-1","author":"A Moradi","year":"2026","unstructured":"Moradi A, Ebrahimian A, Talebi M, Naseri A (2026) The association between depressive symptoms and sleep quality in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. https:\/\/doi.org\/10.1186\/s12883-026-05075-1","journal-title":"BMC Neurol"},{"key":"2429_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ibneur.2026.07.018","volume":"21","author":"R Mosaddeghi-Heris","year":"2026","unstructured":"Mosaddeghi-Heris R, Taheri N, Talebi M, Naseri A (2026) Oxidative stress, depressive symptoms, disability, cognitive outcomes and hand dexterity in relapsing-remitting multiple sclerosis patients with mild\/moderate disability. IBRO Neurosci Rep 21:441\u2013449. https:\/\/doi.org\/10.1016\/j.ibneur.2026.07.018","journal-title":"IBRO Neurosci Rep"},{"key":"2429_CR24","unstructured":"A multicenter double- blind, placebo- controlled study of montelukast on gastrointestinal tolerability in patients with relapsing forms of multiple sclerosis receiving tecfidera\u00ae (Dimethyl Fumarate) delayed release capsules (2015). https:\/\/clinicaltrials.gov\/study\/NCT02410278"},{"key":"2429_CR26","doi-asserted-by":"publisher","first-page":"102816","DOI":"10.1016\/j.msard.2021.102816","volume":"50","author":"A Naseri","year":"2021","unstructured":"Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M (2021) Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 50:102816. https:\/\/doi.org\/10.1016\/j.msard.2021.102816","journal-title":"Mult Scler Relat Disord"},{"key":"2429_CR25","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.msard.2021.103432","volume":"57","author":"A Naseri","year":"2022","unstructured":"Naseri A, Forghani N, Sadigh-Eteghad S, Shanehbandi D, Asadi M, Nasiri E, Talebi M (2022) Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler Relat Disord 57:103432. https:\/\/doi.org\/10.1016\/j.msard.2021.103432","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"2429_CR27","first-page":"170","volume":"31","author":"A Naseri","year":"2025","unstructured":"Naseri A, Sanaie S, Alipour A, Darvishi A, Mosaddeghi-Heris R, Talebi M (2025) The correlation between oxidative stress and fatigue in relapsing-remitting multiple sclerosis. Mult Scler J 31(3):170","journal-title":"Mult Scler J"},{"key":"2429_CR28","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906","journal-title":"Int J Surg"},{"key":"2429_CR29","doi-asserted-by":"publisher","first-page":"1450493","DOI":"10.3389\/fphar.2024.1450493","volume":"15","author":"F Pietrantonio","year":"2024","unstructured":"Pietrantonio F, Serreqi A, Zerbe H, Svenningsson P, Aigner L (2024) The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis: a review. Front Pharmacol 15:1450493. https:\/\/doi.org\/10.3389\/fphar.2024.1450493","journal-title":"Front Pharmacol"},{"key":"2429_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuro.2025.01.004","volume":"107","author":"GN Pires","year":"2025","unstructured":"Pires GN, Laurindo RP, Heringer LDS, da Silva SC, Portela DM, Cardoso R, de P\u00e1dua AC, De S\u00e1 ABM, Cruz D, S. A. A., Santo Ara\u00fajo SE (2025) Therapeutic potential of pranlukast against cuprizone-induced inflammatory demyelination and sensory impairment in mice: Comparison with fingolimod. Neurotoxicology 107:37\u201352","journal-title":"Neurotoxicology"},{"issue":"10","key":"2429_CR31","doi-asserted-by":"publisher","first-page":"e70257","DOI":"10.1111\/jnc.70257","volume":"169","author":"LM Rambo","year":"2025","unstructured":"Rambo LM, Lenz QF, Fava FRT, Milanesi LH, Marafiga JR, Jesse AC, Mello CF (2025) CysLT(1) Receptor activation decreases Na(+)\/K(+)-ATPase activity via PKC-mediated mechanisms in hippocampal slices. J Neurochem 169(10):e70257. https:\/\/doi.org\/10.1111\/jnc.70257","journal-title":"J Neurochem"},{"issue":"1","key":"2429_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.34172\/jrcm.34686","volume":"12","author":"M Sadeghi-Shabestari","year":"2024","unstructured":"Sadeghi-Shabestari M, Abbasnazhad M, Rezazadeh K, Dastranji A (2024) Anti-leukotriene compared to inhaled corticosteroid for recurrent wheezing in children under five years of age: a randomized clinical trial. J Res Clin Med 12(1):40\u201340. https:\/\/doi.org\/10.34172\/jrcm.34686","journal-title":"J Res Clin Med"},{"key":"2429_CR33","doi-asserted-by":"publisher","first-page":"109129","DOI":"10.1016\/j.bioorg.2025.109129","volume":"166","author":"SS Sahoo","year":"2025","unstructured":"Sahoo SS, Paidesetty SK, Sahu PK, Pattanaik S, Dandela R (2025) Therapeutic innovation through drug repurposing: a multidimensional approach toward treating Parkinson\u2019s disease. Bioorg Chem 166:109129. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109129","journal-title":"Bioorg Chem"},{"issue":"1","key":"2429_CR34","doi-asserted-by":"publisher","first-page":"7372789","DOI":"10.1155\/2024\/7372789","volume":"2024","author":"M Shi","year":"2024","unstructured":"Shi M, Liu Y, Gong Q, Xu X (2024) Multiple sclerosis: an overview of epidemiology, risk factors, and serological biomarkers. Acta Neurol Scand 2024(1):7372789. https:\/\/doi.org\/10.1155\/2024\/7372789","journal-title":"Acta Neurol Scand"},{"key":"2429_CR35","doi-asserted-by":"publisher","first-page":"1659852","DOI":"10.3389\/fphar.2025.1659852","volume":"16","author":"M Sobczak","year":"2025","unstructured":"Sobczak M, Pawliczak R (2025) Montelukast: risk of mental disorders vs. efficacy-a meta-analysis. Front Pharmacol 16:1659852. https:\/\/doi.org\/10.3389\/fphar.2025.1659852","journal-title":"Front Pharmacol"},{"issue":"6","key":"2429_CR36","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","volume":"42","author":"M Talebi","year":"2021","unstructured":"Talebi M, Majdi A, Nasiri E, Naseri A, Sadigh-Eteghad S (2021) The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients. Neurol Sci 42(6):2291\u20132300. https:\/\/doi.org\/10.1007\/s10072-020-04807-6","journal-title":"Neurol Sci"},{"key":"2429_CR37","doi-asserted-by":"publisher","unstructured":"Tornatore C, Walsh J, Mann M, Li J, Von Hehn C (2015) Effect of montelukast on gastrointestinal tolerability in patients with relapsing forms of multiple sclerosis receiving delayed-release dimethyl fumarate: a multicenter, randomized, double-blind, placebo-controlled study (MITIGATE) (P1.127). Neurology, 84(14_supplement). P1\u2013127. https:\/\/doi.org\/10.1212\/WNL.84.14_supplement.P1.127","DOI":"10.1212\/WNL.84.14_supplement.P1.127"},{"key":"2429_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/08919887251409836","author":"A Turkistani","year":"2026","unstructured":"Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Eliwa D, Alexiou A, Alnoaman H, Papadakis M, Batiha GE (2026) The possible impact of Montelukast in Parkinson\u2019s disease: a substantial contribution. J Geriatr Psychiatry Neurol. https:\/\/doi.org\/10.1177\/08919887251409836","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2429_CR39","doi-asserted-by":"publisher","first-page":"150479","DOI":"10.1016\/j.brainres.2026.150479","volume":"1890","author":"P Vakilipour","year":"2026","unstructured":"Vakilipour P, Sadigh\u2013Eteghad S, Naseri A, Bonabi MA (2026) Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review. Brain Res 1890:150479. https:\/\/doi.org\/10.1016\/j.brainres.2026.150479","journal-title":"Brain Res"},{"issue":"1\u20132","key":"2429_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s0165-5728(01)00438-6","volume":"121","author":"LW Whitney","year":"2001","unstructured":"Whitney LW, Ludwin SK, McFarland HF, Biddison WE (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121(1\u20132):40\u201348. https:\/\/doi.org\/10.1016\/s0165-5728(01)00438-6","journal-title":"J Neuroimmunol"},{"key":"2429_CR41","doi-asserted-by":"publisher","first-page":"i3518","DOI":"10.1136\/bmj.i3518","volume":"354","author":"DM Wingerchuk","year":"2016","unstructured":"Wingerchuk DM, Weinshenker BG (2016) Disease modifying therapies for relapsing multiple sclerosis. BMJ 354:i3518. https:\/\/doi.org\/10.1136\/bmj.i3518","journal-title":"BMJ"},{"key":"2429_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2022.01.051","volume":"594","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Zhang Y, Gao YH, Zhao ZH, He J, Gao R, Guo YX, Wang LB, Li X (2022) A targeted extracellular vesicles loaded with montelukast in the treatment of demyelinating diseases. Biochem Biophys Res Commun 594:31\u201337. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.051","journal-title":"Biochem Biophys Res Commun"},{"key":"2429_CR43","doi-asserted-by":"publisher","first-page":"101359","DOI":"10.1016\/j.arr.2021.101359","volume":"69","author":"M Yan","year":"2021","unstructured":"Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y, Yang Y, Zhang L (2021) 5-Lipoxygenase as an emerging target against age-related brain disorders. Ageing Res Rev 69:101359. https:\/\/doi.org\/10.1016\/j.arr.2021.101359","journal-title":"Ageing Res Rev"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02429-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:53:10Z","timestamp":1792104790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":43,"alternative-id":["2429"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02429-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Tabriz University of Medical Science reviewed and approved the study protocol (IR.TBZMED.FMD.REC.1405.068).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}